The British Journal of Psychiatry (2008) 193: 345-346. doi: 10.1192/bjp.193.4.345a
© 2008 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Garety, P. A.
Right arrow Articles by Kuipers, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Garety, P. A.
Right arrow Articles by Kuipers, E.

Correspondence

Authors' reply

Philippa A. Garety

Department of Psychology, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF. Email: philipa.garety{at}iop.kcl.ac.uk

David G. Fowler

Department of Psychology and Psychiatry, School of Medicine, University of East Anglia, Norwich

Daniel Freeman

Department of Psychology, Institute of Psychiatry, King's College London

Paul Bebbington

Mental Health Sciences, University College London

Graham Dunn

Health Medical Research Group, Community Based Medicine, University of Manchester

Elizabeth Kuipers

Department of Psychology, Institute of Psychiatry, King's College London, UK

Marlowe notes that the primary outcome of our trial was relapse and comments that it is surprising, therefore, that it was not analysed in more detail. McKenna et al attempt to analyse the relapse data further. Neither Marlowe nor McKenna et al appear to understand the inferential problems raised by the lack of full or partial remission in a considerable proportion of the patients in this trial. The number with full or partial remission is itself an outcome of the trial (i.e. it is a post-randomisation measure). Those who have shown no recovery are excluded from the relapse data that Marlowe and McKenna et al present. In fact, twice as many people show no recovery in TAU as in CBT (18:9). The data reported by Marlowe and McKenna et al are therefore not a causal effect of randomisation (i.e. not an intention-to-treat effect). Because of this problem, we used months in full or partial remission as our primary indicator of outcome for which a formal intention-to-treat analysis is presented. This analysis and also a further examination of total days in hospital and number of admissions very clearly demonstrate that CBT, family intervention and TAU do not differ. We also reported fully on deaths and other adverse events and found no differences (the only completed suicide was in TAU). We are therefore not at all convinced by the suggestion that psychological intervention might be detrimental. Indeed, we infer on the basis of the results of this trial and of numerous meta-analyses (e.g. Pfammatter et al,1 Pilling et al2 and Wykes et al3) that CBT and family intervention are beneficial for certain populations for a range of outcomes.

With respect to the point raised by Marlowe on the effects of having a carer on a psychological intervention, we are of course very aware of the Hogarty et al study,4,5 which we also discuss. It reported mixed findings. Our point here concerned the apparently beneficial effect of having a carer on CBT, which has not been examined before.

REFERENCES

    1
  1. Pfammatter M, Jungham UM, Brenner HD. Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. Schizophr Bull 2006; 32 (suppl 1): s64-80.[CrossRef][Medline]
  2. 2
  3. Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, Morgan C. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 2002; 32: 763 -82.[CrossRef][Medline]
  4. 3
  5. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behaviour therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008; 34: 523-37.[Abstract/Free Full Text]
  6. 4
  7. Hogarty GE, Kornblith SJ, Greenwald P, DiBarry AL, Cooley S, Ulrich RF, Carter M, Flesher S. Three years trials of personal therapy with schizophrenics living with or independent of family. I: Description of study and effects on relapse rates. Am J Psychiatry 1997; 154: 1504 -13.[Abstract/Free Full Text]
  8. 5
  9. Hogarty GE, Greenwald P, Ulrich RF, Kornblith SJ, DiBarry AL, Cooley S, Carter M, Flesher S. Three years trials of personal therapy with schizophrenics living with or independent of family. II: Effects on adjustment of patients. Am J Psychiatry 1997; 154: 1514 -24.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Garety, P. A.
Right arrow Articles by Kuipers, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Garety, P. A.
Right arrow Articles by Kuipers, E.